Barclays Trims Molina Healthcare (NYSE:MOH) Target Price to $430.00

Molina Healthcare (NYSE:MOH) had its target price cut by Barclays from $437.00 to $430.00 in a report published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the stock.

A number of other equities analysts have also commented on MOH. Cantor Fitzgerald restated an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a research report on Thursday, April 4th. Wells Fargo & Company reduced their target price on shares of Molina Healthcare from $440.00 to $410.00 and set an equal weight rating on the stock in a research report on Monday, April 15th. StockNews.com lowered shares of Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. Stephens reiterated an equal weight rating and set a $390.00 target price on shares of Molina Healthcare in a research report on Thursday. Finally, Truist Financial upped their target price on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research report on Tuesday, February 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company has an average rating of Hold and a consensus price target of $396.09.

Molina Healthcare Price Performance

NYSE:MOH opened at $342.23 on Thursday. The firm has a market cap of $20.05 billion, a PE ratio of 18.57, a price-to-earnings-growth ratio of 0.96 and a beta of 0.47. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a quick ratio of 1.54, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The company’s 50-day moving average price is $390.34 and its two-hundred day moving average price is $372.12.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. The firm had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period in the previous year, the business earned $5.81 earnings per share. On average, equities analysts anticipate that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold 16,711 shares of company stock worth $6,472,517 over the last ninety days. Company insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Large investors have recently bought and sold shares of the company. Annis Gardner Whiting Capital Advisors LLC bought a new stake in Molina Healthcare in the third quarter valued at approximately $30,000. McIlrath & Eck LLC bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $34,000. VisionPoint Advisory Group LLC increased its stake in Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock valued at $36,000 after purchasing an additional 57 shares in the last quarter. Principal Securities Inc. bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $42,000. Finally, Friedenthal Financial bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $43,000. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.